The Coronavirus pandemic has put considerable strain on businesses of all sizes, but some sectors have proved more resilient to lockdown pressures than others. It comes as no surprise that big tech has fared well over the past 12 months, but other more traditional sectors, too, have proved buoyant in testing times

In a heavily regulated industry, it can be difficult to stay afloat. Megalabs outlines some of the challenges and pitfalls faced by pharmaceutical companies, and explains the necessary steps that must be taken to become a leader in the field

Home to 12 of the world’s top 20 grossing pharmaceutical companies, Puerto Rico is primed to expand its life sciences manufacturing base in response to the COVID-19 pandemic

With the latest saga in the counterfeit pharmaceutical industry concerning fake paracetamol, the Philippines finds itself facing a public health crisis

Courage and persistence are critical to good leadership, explains the Alvogen chairman and CEO

The founder and CEO of Alvogen shows us the napkin on which he first pitched his vision for the generic pharmaceuticals business

Robert Wessman explains that with just three US companies controlling half the world’s pharmaceutical sales, 100+ generics companies are unsustainable

Last year saw one of the most significant deals ever completed in the generic pharmaceuticals industry. Teva Pharmaceuticals explains what has made the acquisition such a great success

Arrests have been made over an illegal scheme between a former Valeant senior director and online Pharmacy Philidor

Cross-border acquisitions are becoming increasingly common, but some governments are not overly happy to pass control of key industries into foreign hands